Cargando…

New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication

BACKGROUND: Persistent hepatitis C virus (HCV) infection causes chronic liver diseases and is a global health problem. Although new triple therapy (pegylated-interferon, ribavirin, and telaprevir/boceprevir) has recently been started and is expected to achieve a sustained virologic response of more...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueda, Youki, Takeda, Midori, Mori, Kyoko, Dansako, Hiromichi, Wakita, Takaji, Kim, Hye-Sook, Sato, Akira, Wataya, Yusuke, Ikeda, Masanori, Kato, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758303/ https://www.ncbi.nlm.nih.gov/pubmed/24023620 http://dx.doi.org/10.1371/journal.pone.0072519

Ejemplares similares

Correction: New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication
por: Ueda, Youki, et al.
Publicado: (2013)

Raloxifene inhibits hepatitis C virus infection and replication
por: Takeda, Midori, et al.
Publicado: (2012)

Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activities
por: Gu, Weilin, et al.
Publicado: (2021)

Establishment of Hepatitis C Virus RNA-Replicating Cell Lines Possessing Ribavirin-Resistant Phenotype
por: Satoh, Shinya, et al.
Publicado: (2015)

Genetic Characterization of Hepatitis C Virus in Long-Term RNA Replication Using Li23 Cell Culture Systems
por: Kato, Nobuyuki, et al.
Publicado: (2014)

ULBP1 is induced by hepatitis C virus infection and is the target of the NK cell‐mediated innate immune response in human hepatocytes
por: Dansako, Hiromichi, et al.
Publicado: (2018)

Ribavirin suppresses hepatic lipogenesis through inosine monophosphate dehydrogenase inhibition: Involvement of adenosine monophosphate‐activated protein kinase‐related kinases and retinoid X receptor α
por: Satoh, Shinya, et al.
Publicado: (2017)

The ESCRT System Is Required for Hepatitis C Virus Production
por: Ariumi, Yasuo, et al.
Publicado: (2011)

Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251
por: Ueda, Youki, et al.
Publicado: (2018)

High‐level expression of STING restricts susceptibility to HBV by mediating type III IFN induction
por: Dansako, Hiromichi, et al.
Publicado: (2018)

Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
por: Watanabe, Tomofumi, et al.
Publicado: (2023)

Combination therapy with hydrogen peroxide and irradiation promotes an abscopal effect in mouse models
por: Kemmotsu, Naoya, et al.
Publicado: (2023)

Class A Scavenger Receptor 1 (MSR1) Restricts Hepatitis C Virus Replication by Mediating Toll-like Receptor 3 Recognition of Viral RNAs Produced in Neighboring Cells
por: Dansako, Hiromichi, et al.
Publicado: (2013)

Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362
por: Lowe, Martin A., et al.
Publicado: (2022)

Potent Antimalarial Activity of Acriflavine In Vitro and In Vivo
por: Dana, Srikanta, et al.
Publicado: (2014)

Synthesis and Potent Antimalarial Activity of Kalihinol B
por: Daub, Mary Elisabeth, et al.
Publicado: (2015)

Structural Optimization of BIPPO Analogs as Potent Antimalarials
por: Zheng, Yang, et al.
Publicado: (2023)

Replication of a hepatitis C virus replicon clone in mouse cells
por: Uprichard, Susan L, et al.
Publicado: (2006)

MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis
por: Edwards, Rachel L., et al.
Publicado: (2017)

Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities
por: Basilico, Nicoletta, et al.
Publicado: (2023)

Development and Use of a Kinetical and Real-Time Monitoring System to Analyze the Replication of Hepatitis C Virus
por: Li, Xiaoyu, et al.
Publicado: (2022)

Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
por: de Vries, Laura E., et al.
Publicado: (2022)

Diastereoselective Synthesis of Potent Antimalarial Cis-β-lactam Agents
por: Jarrahpour, Aliasghar, et al.
Publicado: (2019)

Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity
por: Aguiar, Anna C.C., et al.
Publicado: (2018)

Robenidine Analogues Are Potent Antimalarials in Drug-Resistant Plasmodium falciparum
por: Krollenbrock, Alina, et al.
Publicado: (2021)

Cooperation Between Japan’s NIID and China CDC in Japan’s COVID-19 Response
por: Wakita, Takaji
Publicado: (2020)

Replication of Hepatitis C Virus in Cultured Non‐neoplastic Human Hepatocytes
por: Kato, Nobuyuki, et al.
Publicado: (1996)

Visualization and Measurement of ATP Levels in Living Cells Replicating Hepatitis C Virus Genome RNA
por: Ando, Tomomi, et al.
Publicado: (2012)

Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction
por: Tsukamoto, Yuta, et al.
Publicado: (2018)

RNA Polymerase Activity and Specific RNA Structure Are Required for Efficient HCV Replication in Cultured Cells
por: Murayama, Asako, et al.
Publicado: (2010)

Completion of the Entire Hepatitis C Virus Life Cycle in Vero Cells Derived from Monkey Kidney
por: Murayama, Asako, et al.
Publicado: (2016)

Involvement of FKBP6 in hepatitis C virus replication
por: Kasai, Hirotake, et al.
Publicado: (2015)

Potent in vivo antimalarial activity of water-soluble artemisinin nano-preparations
por: Valissery, Praveesh, et al.
Publicado: (2020)

Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
por: Shionoya, Kaho, et al.
Publicado: (2021)

Repurposing antimalarial artesunate for the prophylactic treatment of depression: Evidence from preclinical research
por: Huang, Shihao, et al.
Publicado: (2022)

Pyrazoleamide compounds are potent antimalarials that target Na(+) homeostasis in intraerythrocytic Plasmodium falciparum
por: Vaidya, Akhil B., et al.
Publicado: (2014)

Synthesis of 4-aminoquinoline–pyrimidine hybrids as potent antimalarials and their mode of action studies
por: Singh, Kamaljit, et al.
Publicado: (2013)

Diatretol, an α, α′-dioxo-diketopiperazine, is a potent in vitro and in vivo antimalarial
por: Ishiyama, Aki, et al.
Publicado: (2021)

Substrate Peptidomimetic Inhibitors of P. falciparum Plasmepsin X with Potent Antimalarial Activity
por: Richardson, Lachlan W., et al.
Publicado: (2022)

Macrocyclic Peptidomimetic Plasmepsin X Inhibitors with Potent In Vitro and In Vivo Antimalarial Activity
por: Kovada, Vadims, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bo9s43iddlvl4m38hkb1maq337